They realized that PTEN/AKT mutations appeared in a high percentage in TAL- or LMO-rearranged leukaemia, although PTEN/AKT mutations did not appear in TLX3-rearranged patients (P = 0.03). This evidence concerns the gene AKT1 and leukemia.